Applying AI to Real-World Data to Improve Pharmaceutical Development
January 18, 2022 | Trends from the Trenches—Xiong Sean Liu is a Director at Novartis where he has been working to make inroads for AI in pharma. In Liu’s view, AI as...
Category: Industry News
WHAT IS SYNTHETIC DATA, AND WHY WILL IT BE SO IMPORTANT?
January 14, 2022 By Joseph Moss, International Banker We are now comfortably in the era of data, with more and more of it being generated with every passing year. And looking...
Uncovering Real-World Patient Insights With Social Media and NLP
Historically, drug researchers have relied on methods such as focus groups, interviews and questionnaires for first-person accounts of patient-reported outcomes, views, symptoms, use of competitive products and other relevant data...
Digital health funding reaches record $29.1B in 2021
Dive Brief: U.S. digital health startups nabbed a record $29.1 billion in funding in 2021, nearly double the investment volume in the year prior, according to a new report from Rock Health....
MHRA Guidance on the use of Real-World Data in Clinical Studies for Regulatory Decision-Making Supports Albert Labs’ Licensing Pathway
VANCOUVER, BC, Jan. 4, 2022 /CNW/ – On the 17th December 2021 the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) produced guidance acknowledging and setting out the criteria for the use of Real...
Australia’s device reforms mostly completed, but postmarketing efforts take central stage
By Tamra Sami PERTH, Australia – Australia’s Therapeutic Goods Administration (TGA) has undertaken a massive effort to reform its drug and device regulations, and as it pulls into the homestretch with those reforms,...
UK Explains How To Plan For Randomized Trials Using Mainly RWD Sources
31 Dec 2021 NEWS Â Vibha Sharma Executive Summary The UK Medicines and Healthcare products Regulatory Agency has finalized the first part of a series of new guidance documents addressing issues...
AstraZeneca and G42 Healthcare partner to boost research and diagnostics in the UAE
The companies will reportedly focus on exploring real-world evidence and conducting clinical trials through G42 Healthcare’s Contract Research Organisation, IROS.By Rachel McArthurDecember 24, 202108:37 AM Credit: iStock AstraZeneca has teamed...
UK’s MHRA posts guidelines for use of real-world evidence, but med tech in limbo
By Mark McCarty The U.K. Medicines and Healthcare Products Regulatory Agency (MHRA) has unveiled two guidances for the use of real-world evidence (RWE) in regulatory decision-making. The policy seems limited to pharmaceutical clinical...
Real-World Data Underscores Efficacy of Durvalumab in NSCLC
Real-world data from the PACIFIC-R trial (NCT03798535) evaluating durvalumab (Imfinizi) following chemoradiotherapy in patients with stage III, unresectable non–small cell lung cancer (NSCLC) provide evidence supporting the agent’s efficacy in...